Saturday 17 October 2026
Export CBT’s income statement to Excel — free account
Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024. In the quarter to June 2026, revenue grew 6.39%, EPS fell 93.6%, free cash flow fell 77.0% and total debt rose 4.77%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
74.29
1.19
−1.58%
Follow CBT
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to September
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 36.12 | 50.21 | 39.57 | 37.11 | 20.00 | 42.72 | 53.32 | 63.73 | 70.63 | 58.33 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 54.24 | 64.66 | 68.63 | 50.58 | 48.18 | 65.25 | 78.62 | 86.67 | 117.46 | 92.89 | |||||
| People | |||||||||||||||
| People | Employees | 4,300 | 4,500 | 4,600 | 4,500 | 4,500 | 4,500 | 4,200 | 4,300 | 4,200 | 4,100 | ||||
| Revenue/emp, $m | 0.56 | 0.60 | 0.70 | 0.74 | 0.58 | 0.76 | 1.03 | 0.91 | 0.95 | 0.91 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 2,411 | 2,717 | 3,242 | 3,337 | 2,614 | 3,409 | 4,321 | 3,931 | 3,994 | 3,713 | ||||
| Gross margin, % | 23.85 | 24.18 | 23.81 | 20.53 | 19.13 | 23.44 | 20.48 | 21.34 | 24.04 | 25.32 | |||||
| EBT | 191 | 299 | 117 | 255 | (33) | 406 | 335 | 451 | 529 | 565 | |||||
| EBT margin, % | 7.92 | 11.00 | 3.61 | 7.64 | (1.26) | 11.91 | 7.75 | 11.47 | 13.24 | 15.22 | |||||
| Net income | 162 | 273 | (74) | 186 | (221) | 286 | 243 | 484 | 424 | 376 | |||||
| Depreciation | 161 | 155 | 241 | 148 | 158 | 160 | 146 | 144 | 151 | 154 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 38.64 | 43.61 | 52.54 | 56.85 | 46.18 | 60.12 | 76.48 | 70.07 | 72.49 | 69.14 | ||||
| Earnings | 2.36 | 3.81 | (1.85) | 2.63 | (4.21) | 4.34 | 3.62 | 7.73 | 6.72 | 6.07 | |||||
| Cash flow | 6.28 | 5.59 | 4.83 | 6.18 | 6.66 | 4.53 | 1.77 | 10.61 | 12.56 | 12.38 | |||||
| Capex | (1.54) | (2.36) | (3.08) | (3.82) | (3.53) | (3.44) | (3.42) | (4.22) | (4.37) | (5.10) | |||||
| Free cash flow | 4.74 | 3.23 | 1.75 | 2.37 | 3.13 | 1.09 | (1.65) | 6.38 | 8.19 | 7.28 | |||||
| Book value | 21.99 | 26.08 | 20.73 | 19.32 | 14.38 | 19.22 | 18.27 | 25.08 | 28.86 | 31.75 | |||||
| Shares, m | 62 | 62 | 62 | 59 | 57 | 57 | 57 | 56 | 55 | 54 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 22.21 | 15.06 | 0.00 | 17.23 | 0.00 | 11.55 | 17.75 | 8.78 | 16.58 | 12.55 | ||||
| P/S | 1.36 | 1.32 | 1.19 | 0.80 | 0.78 | 0.83 | 0.84 | 0.97 | 1.54 | 1.10 | |||||
| P/B | 2.38 | 2.20 | 3.03 | 2.35 | 2.51 | 2.61 | 3.50 | 2.71 | 3.87 | 2.40 | |||||
| EV/Sales | 1.65 | 1.55 | 1.45 | 1.07 | 1.15 | 1.13 | 1.12 | 1.24 | 1.77 | 1.33 | |||||
| EV/FCF | 13.46 | 20.99 | 43.52 | 25.58 | 16.97 | 61.87 | (52.12) | 13.56 | 15.69 | 12.67 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 392 | 348 | 298 | 363 | 377 | 257 | 100 | 595 | 692 | 665 | ||||
| Capex | (96) | (147) | (190) | (224) | (200) | (195) | (193) | (237) | (241) | (274) | |||||
| Free cash flow | 296 | 201 | 108 | 139 | 177 | 62 | (93) | 358 | 451 | 391 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 650 | 557 | 434 | 611 | 449 | 278 | 715 | 804 | 833 | 582 | ||||
| Total debt | 915 | 924 | 1,003 | 1,064 | 1,115 | 1,162 | 1,443 | 1,276 | 1,140 | 1,130 | |||||
| Net debt | 715 | 644 | 828 | 895 | 964 | 994 | 1,237 | 1,038 | 917 | 872 | |||||
| Shareholders’ equity | 1,372 | 1,625 | 1,279 | 1,134 | 814 | 1,090 | 1,032 | 1,407 | 1,590 | 1,705 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 4.78 | 7.78 | (3.46) | 5.03 | (8.23) | 8.21 | 6.12 | 12.48 | 10.35 | 8.77 | ||||
| ROIC | 7.40 | 9.31 | 4.27 | 9.43 | 0.74 | 13.62 | 10.72 | 13.45 | 15.31 | 15.06 | |||||
| ROE | 10.77 | 16.55 | (7.85) | 13.01 | (24.44) | 26.26 | 19.70 | 36.49 | 25.36 | 20.09 | |||||
Negative figures in brackets.
Fiscal years to Sep 2025 · latest quarter Jun 2026
Charts ten years each
Cabot Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BCPC Balchem Corporation | $5.4B | 33.5× | 30.5× | +11.17% (above 0%: growing) | +18.80% (above 0%: growing) | −11.98% (below 0%: shrinking) | 36.51% | 20.85% | Compare |
| CLMT Calumet, Inc. | $5.1B | — (loss-making) | — (loss-making) | +40.77% (above 0%: growing) | n/m | +450.65% (above 0%: growing) | 1.27% | (2.77%) | Compare |
| PRM Perimeter Solutions, SA | $4.5B | — (loss-making) | 14.0× | +31.46% (above 0%: growing) | n/m | +56.62% (above 0%: growing) | 55.13% | (94.95%) | Compare |
| CBT Cabot Corporation | $3.9B | 20.9× | 8.6× | +6.39% (above 0%: growing) | −93.58% (below 0%: shrinking) | −77.02% (below 0%: shrinking) | 18.74% | 9.98% | |
| AVNT Avient Corporation | $3.6B | 21.0× | 14.0× | +5.83% (above 0%: growing) | +24.56% (above 0%: growing) | −16.67% (below 0%: shrinking) | 33.54% | 12.26% | Compare |
| ASH Ashland Inc. | $3.3B | 62.4× | 24.9× | +7.34% (above 0%: growing) | n/m | +5.26% (above 0%: growing) | 34.21% | 8.65% | Compare |
| FUL H. B. Fuller Company | $2.8B | 14.1× | 16.8× | +5.17% (above 0%: growing) | +18.19% (above 0%: growing) | −58.41% (below 0%: shrinking) | 33.22% | 12.07% | Compare |
| HWKN Hawkins, Inc. | $2.8B | 33.8× | 36.3× | +7.64% (above 0%: growing) | −3.55% (below 0%: shrinking) | +30.29% (above 0%: growing) | 23.44% | 12.25% | Compare |
| KWR Quaker Houghton | $2.7B | 27.9× | 25.2× | +10.17% (above 0%: growing) | n/m | −43.19% (below 0%: shrinking) | 35.53% | 7.62% | Compare |
| Median of peers | $3.4B | 30.7× | 24.9× | +8.90% | +18.50% | −3.36% | 33.88% | 10.36% |
Cabot Corporation (CBT) key facts
- Concern: Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Concern: Net income was $376.0 million, or $6.07 per share (basic), a net margin of 8.91%.
- Cabot Corporation (CBT) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
- As of October 16, 2026, CBT traded at $74.29, a market capitalization of $3.9 billion.
- At that price the stock trades at 20.9× trailing-twelve-month earnings and 1.1× sales; its P/E is higher than 73% of its own readings over the past ten years.
- Cabot Corporation pays an annual dividend of $1.85 per share, a yield of 2.48%, with a payout ratio of 52.0%.
- Return on equity was 20.1% and debt-to-equity 0.73.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 3.53 (safe zone) for fiscal 2025.